# PDL1 positivity, maximum 5%





![](PDL1_pos_5_max_files/figure-html/PDL1_pos_5_max-1.png) 

|       | PDL1 negative |  %   | PDL1 positive |  %   |
|:------|:-------------:|:----:|:-------------:|:----:|
|Female |      31       | 36.9 |       8       | 53.3 |
|Male   |      53       | 63.1 |       7       | 46.7 |

![](PDL1_pos_5_max_files/figure-html/PDL1_pos_5_max-2.png) 

|                    | PDL1 negative | PDL1 positive |
|:-------------------|:-------------:|:-------------:|
|Mean                |     70.0      |     69.9      |
|Standard Deviation  |      9.2      |      7.8      |
|Median              |     71.0      |     72.0      |
|Interquartile Range |     12.2      |      7.0      |
|Minimum             |     48.0      |     51.0      |
|Maximum             |     87.0      |     81.0      |

![](PDL1_pos_5_max_files/figure-html/PDL1_pos_5_max-3.png) 

|              | PDL1 negative |  %   | PDL1 positive |  %   |
|:-------------|:-------------:|:----:|:-------------:|:----:|
|Pelvis        |      39       | 46.4 |       6       | 40.0 |
|Pelvis-Ureter |       3       | 3.6  |       1       | 6.7  |
|Ureter        |      42       | 50.0 |       8       | 53.3 |

![](PDL1_pos_5_max_files/figure-html/PDL1_pos_5_max-4.png) 

|    | PDL1 negative |  %   | PDL1 positive |  %   |
|:---|:-------------:|:----:|:-------------:|:----:|
|pTa |      17       | 20.2 |       2       | 13.3 |
|pT1 |      16       | 19.0 |       2       | 13.3 |
|pT2 |       8       | 9.5  |       0       | 0.0  |
|pT3 |      41       | 48.8 |       7       | 46.7 |
|pT4 |       2       | 2.4  |       4       | 26.7 |

![](PDL1_pos_5_max_files/figure-html/PDL1_pos_5_max-5.png) 

|    | PDL1 negative |  %   | PDL1 positive |  %   |
|:---|:-------------:|:----:|:-------------:|:----:|
|No  |      41       | 48.8 |       4       | 26.7 |
|Yes |      43       | 51.2 |      11       | 73.3 |

![](PDL1_pos_5_max_files/figure-html/PDL1_pos_5_max-6.png) 

|        | PDL1 negative |  %   | PDL1 positive |  %   |
|:-------|:-------------:|:----:|:-------------:|:----:|
|Grade 1 |       7       | 8.3  |       0       | 0.0  |
|Grade 2 |      34       | 40.5 |       5       | 33.3 |
|Grade 3 |      43       | 51.2 |      10       | 66.7 |

![](PDL1_pos_5_max_files/figure-html/PDL1_pos_5_max-7.png) 

|    | PDL1 negative |  %   | PDL1 positive | %  |
|:---|:-------------:|:----:|:-------------:|:--:|
|No  |      12       | 14.3 |       3       | 20 |
|Yes |      72       | 85.7 |      12       | 80 |

![](PDL1_pos_5_max_files/figure-html/PDL1_pos_5_max-8.png) 

|    | PDL1 negative |  %   | PDL1 positive |  %   |
|:---|:-------------:|:----:|:-------------:|:----:|
|No  |      73       | 90.1 |      11       | 73.3 |
|Yes |       8       | 9.9  |       4       | 26.7 |

![](PDL1_pos_5_max_files/figure-html/PDL1_pos_5_max-9.png) 

|    | PDL1 negative |  %   | PDL1 positive | %  |
|:---|:-------------:|:----:|:-------------:|:--:|
|No  |      53       | 63.1 |       6       | 40 |
|Yes |      31       | 36.9 |       9       | 60 |

![](PDL1_pos_5_max_files/figure-html/PDL1_pos_5_max-10.png) 

|    | PDL1 negative |  %   | PDL1 positive | %  |
|:---|:-------------:|:----:|:-------------:|:--:|
|No  |      53       | 64.6 |      12       | 80 |
|Yes |      29       | 35.4 |       3       | 20 |

![](PDL1_pos_5_max_files/figure-html/PDL1_pos_5_max-11.png) 

|    | PDL1 negative |  %   | PDL1 positive |  %   |
|:---|:-------------:|:----:|:-------------:|:----:|
|No  |      29       | 40.8 |       5       | 41.7 |
|Yes |      42       | 59.2 |       7       | 58.3 |

![](PDL1_pos_5_max_files/figure-html/PDL1_pos_5_max-12.png) 

|                    | PDL1 negative | PDL1 positive |
|:-------------------|:-------------:|:-------------:|
|Mean                |     55.3      |     51.9      |
|Standard Deviation  |     39.6      |     43.2      |
|Median              |     47.5      |     44.0      |
|Interquartile Range |     54.2      |     71.5      |
|Minimum             |      3.0      |      4.0      |
|Maximum             |     173.0     |     158.0     |

![](PDL1_pos_5_max_files/figure-html/PDL1_pos_5_max-13.png) 

|    | PDL1 negative |  %   | PDL1 positive |  %   |
|:---|:-------------:|:----:|:-------------:|:----:|
|No  |      61       | 72.6 |       8       | 53.3 |
|Yes |      23       | 27.4 |       7       | 46.7 |

![](PDL1_pos_5_max_files/figure-html/PDL1_pos_5_max-14.png) 



# Odds ratios for local tumor recurrence

|Variables                         |  OR   | Lower 95% CI | Higher 95% CI | P value |
|:---------------------------------|:-----:|:------------:|:-------------:|:-------:|
|Patient's sex                     | 1.45  |     0.60     |     3.66      |  0.42   |
|Patient's age group               | 0.97  |     0.41     |     2.30      |  0.95   |
|Tumor location (pelvis vs ureter) | 1.16  |     0.48     |     2.82      |  0.74   |
|High pT (>pT2) stage              | 23.15 |     6.25     |    150.95     | 4.8e-05 |
|High histologic grade             | 7.38  |     1.38     |    137.08     |  0.059  |
|Lymph node metastasis             | 3.71  |     1.08     |     13.69     |  0.039  |
|Lymphovascular invasion           | 7.79  |     3.06     |     21.66     | 3.4e-05 |
|PDL1 positivity                   | 2.32  |     0.74     |     7.20      |  0.14   |

# Odds ratios for tumor progression

|Variables                         |  OR   | Lower 95% CI | Higher 95% CI | P value |
|:---------------------------------|:-----:|:------------:|:-------------:|:-------:|
|Patient's sex                     | 0.83  |     0.33     |     2.01      |  0.67   |
|Patient's age group               | 0.50  |     0.20     |     1.22      |  0.13   |
|Tumor location (pelvis vs ureter) | 1.14  |     0.47     |     2.76      |  0.78   |
|High pT (>pT2) stage              | 5.23  |     2.07     |     13.97     | 0.00064 |
|High histologic grade             | 3e+08 |   9.7e-40    |      NA       |  0.99   |
|Lymph node metastasis             | 3.12  |     0.72     |     21.65     |  0.17   |
|Lymphovascular invasion           | 3.99  |     1.56     |     11.06     | 0.0053  |
|PDL1 positivity                   | 0.97  |     0.28     |     3.54      |  0.96   |

# Odds ratios for cancer-related death

|Variables                         |  OR   | Lower 95% CI | Higher 95% CI | P value |
|:---------------------------------|:-----:|:------------:|:-------------:|:-------:|
|Patient's sex                     | 1.45  |     0.60     |     3.66      |  0.42   |
|Patient's age group               | 0.97  |     0.41     |     2.30      |  0.95   |
|Tumor location (pelvis vs ureter) | 1.16  |     0.48     |     2.82      |  0.74   |
|High pT (>pT2) stage              | 23.15 |     6.25     |    150.95     | 4.8e-05 |
|High histologic grade             | 7.38  |     1.38     |    137.08     |  0.059  |
|Lymph node metastasis             | 3.71  |     1.08     |     13.69     |  0.039  |
|Lymphovascular invasion           | 7.79  |     3.06     |     21.66     | 3.4e-05 |
|PDL1 positivity                   | 2.32  |     0.74     |     7.20      |  0.14   |

# Hazard ratios for cancer-related death

|Variables                         |  HR   | Lower 95% CI | Higher 95% CI | P value |
|:---------------------------------|:-----:|:------------:|:-------------:|:-------:|
|Patient's sex                     | 1.33  |     0.75     |     0.62      |  0.45   |
|Patient's age group               | 0.77  |     1.29     |     0.37      |  0.49   |
|Tumor location (pelvis vs ureter) | 1.21  |     0.82     |     0.58      |   0.6   |
|High pT (>pT2) stage              | 17.63 |    0.057     |     4.19      | 1.1e-08 |
|High histologic grade             | 7.79  |     0.13     |     1.06      | 0.0045  |
|Lymph node metastasis             | 2.76  |     0.36     |     1.18      |  0.033  |
|Lymphovascular invasion           | 5.64  |     0.18     |     2.50      | 6.1e-06 |
|PDL1 positivity                   | 1.78  |     0.56     |     0.76      |   0.2   |

